{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:37Z","timestamp":1787169877291,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The purpose of the study is to identify early serum sodium changes that could happen in elderly patients with nocturia receiving desmopressin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study was conducted on 28 patients complaining of nocturia and receiving desmopressin. Inclusion criteria were patients diagnosed as having nocturia (at least one or more voids per night) aging \u226555 years with normal baseline serum sodium (135\u2013150 mEq\/L). All patients received desmopressin in the form of 60 \u03bcg at bedtime. Close follow-up was done for any adverse effects that may have occurred related to hyponatremia and serum sodium was reevaluated for all patients at 3, 7, 14, and 30 days from the start of the treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Desmopressin resulted in a significant decrease in nocturnal urine volume, a decrease in nocturnal polyuria index, number of night voids and the time to first void was delayed. Furthermore, statistically insignificant sodium drop in males and statistically significant sodium drop in females were noted with infrequent side effects, for example, headache (10.7%) and hyponatremia (7.14%) that started after treatment by 1 week.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hyponatremia can be avoided using the minimal effective dose of desmopressin. To receive desmopressin in elderly patients sodium baseline level must be \u2265135 mmol\/L. Close sodium monitoring has to be done at 7, 14, and 30 days from start of treatment for high-risk patients (especially elderly) or patients receiving other medication causing hyponatremia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ua.ua_61_22","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:08:14Z","timestamp":1697774894000},"page":"393-397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Early serum sodium changes in elderly patients with nocturia receiving desmopressin"],"prefix":"10.4103","volume":"15","author":[{"given":"Mohamed","family":"Abuelnaga","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Mourad","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Satour","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaaeldin","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3346\/jkms.2010.25.12.1792","article-title":"Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ijcp.12786","article-title":"Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice","volume":"70","author":"Chen","year":"2016","journal-title":"Int J Clin Pract"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0970-1591.42607","article-title":"Practical management of nocturia in urology","volume":"24","author":"Jin","year":"2008","journal-title":"Indian J Urol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1464-410X.2002.02791.x","article-title":"Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men","volume":"89","author":"Mattiasson","year":"2002","journal-title":"BJU Int"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1507\/endocrj.EJ14-0368","article-title":"Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus","volume":"62","author":"Kataoka","year":"2015","journal-title":"Endocr J"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.juro.2013.02.037","article-title":"Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: Results of a multicenter, randomized, double-blind, placebo controlled, parallel group study","volume":"190","author":"Sand","year":"2013","journal-title":"J Urol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","article-title":"Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: Results of a multicenter, randomized, double-blind, placebo controlled, parallel group study","volume":"190","author":"Weiss","year":"2013","journal-title":"J Urol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bju.13718","article-title":"Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia","volume":"119","author":"Juul","year":"2017","journal-title":"BJU Int"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1389-9457(00)00029-0","article-title":"Nighttime sleep and daytime functioning (sleepiness and fatigue) in well-defined chronic rheumatic diseases","volume":"1","author":"Mahowald","year":"2000","journal-title":"Sleep Med"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1464-410x.1999.00157.x","article-title":"Mortality in the elderly in relation to nocturnal micturition","volume":"84","author":"Asplund","year":"1999","journal-title":"BJU Int"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.10053","article-title":"The standardisation of terminology in nocturia: Report from the Standardisation Sub-Committee of the International Continence Society","volume":"21","author":"van Kerrebroeck","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/2473-6430\/3\/2\/00131","article-title":"Therapeutic efficacy and safety of oral desmopressin for nocturia in the elderly patient","volume":"3","author":"Navalon","year":"2017","journal-title":"J Urol Nephrol Open Access"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.20168","article-title":"Desmopressin treatment in nocturia;an analysis of risk factors for hyponatremia","volume":"25","author":"Rembratt","year":"2006","journal-title":"Neurourol Urodyn"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_61_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:23Z","timestamp":1787166863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ua.ua_61_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ua.ua_61_22","relation":{},"ISSN":["0974-7796","0974-7834"],"issn-type":[{"value":"0974-7796","type":"print"},{"value":"0974-7834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2022-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}